低级别钝性腹部实质脏器损伤患儿很少需要院内干预:TQIP登记分析
该回顾性队列分析美国外科医师学会创伤质量改进计划(TQIP)登记(2007-2017)中年龄<16岁、钝性腹部实质脏器损伤AAST分级1或2级、且排除合并症、其他重大损伤或腹外手术的患儿共1019例。96.8%收入住院,中位住院2天,ICU入住率23.9%,仅1.7%(17例)接受干预(剖腹探查、血管造影或输血),中位干预时间为入院第1天;接受血管造影者均未输血且初始急诊休克指数正常。作者据此质疑常规住院的必要性,提出急诊离院可能安全,但需前瞻性研究验证。
要点
- 1019例低级别钝性腹部实质脏器损伤且无其他重大损伤患儿中,仅1.7%(17例)接受干预,中位干预时间为入院第1天。
- 96.8%患儿收入住院,中位住院时间2天,ICU入住率23.9%,提示资源利用与干预需求不匹配。
- 接受血管造影的患儿均未输血,且初始急诊休克指数均正常,原文认为该队列中血管造影指征存疑。
- 原文结论质疑低级别损伤常规住院的必要性,提出急诊离院可能安全,但需前瞻性验证。
- 证据等级为预后与流行病学III级,属登记库回顾性分析,不能据此直接改变常规收治策略。
适用人群与场景
- 年龄<16岁、钝性腹部实质脏器损伤、AAST分级1或2级、无其他重大损伤(OMIs)的患儿;数据来自美国外科医师学会TQIP登记(2007-2017)。
- 排除标准:存在与出血干预相关的混杂因素,包括合并症、其他重大损伤(OMIs)或腹外手术操作。
- 场景为急诊就诊后决定收治或离院的阶段,原文未限定院前或ICU特定阶段。
诊断标准与关键阈值
- 损伤分级采用美国创伤外科协会(AAST)钝性腹部实质脏器损伤分级,纳入1级或2级。
- 原文未提及启动干预的具体评分界值或休克指数阈值,仅描述接受血管造影者初始急诊休克指数无异常。
处置流程与药物剂量
- 原文未提及具体的处置流程或药物剂量方案;仅报告结局指标包括剖腹探查、血管造影或输血等出血干预的频率与时机。
- 原文未给出低级别损伤患儿急诊离院的具体标准或随访方案,仅提出急诊离院可能安全并需前瞻性验证。
红旗征与不能漏的情况
- 原文未提及具体的红旗征或需立刻处理的情况;仅指出接受血管造影者均未输血且初始急诊休克指数正常,原文认为该队列中血管造影指征存疑。
研究设计与关键结果
- 研究类型:回顾性队列分析,基于美国外科医师学会TQIP登记(2007-2017),共1019例低级别钝性腹部实质脏器损伤且无其他重大损伤的患儿。
- 仅1.7%(17例)接受干预(剖腹探查、血管造影或输血),中位干预时间为入院第1天。
- 接受血管造影的患儿均未输血,且初始急诊休克指数均正常。
证据类型、等级与局限
- 证据类型:基于TQIP登记库的回顾性队列研究(预后与流行病学),证据等级III级。
- 局限:回顾性登记数据分析,可能存在未测量的混杂因素;原文指出需要前瞻性研究识别罕见需院内干预的风险因素,并验证门诊管理(急诊离院)的安全性。
对床旁实践的改变
- 原文数据质疑低级别钝性腹部实质脏器损伤且无其他重大损伤患儿常规住院的必要性,提出急诊离院可能安全,但未给出可直接应用的离院标准。
- 原文指出该队列中血管造影指征存疑(接受血管造影者均未输血且初始急诊休克指数正常),提示应审慎评估低级别损伤患儿行血管造影的必要性。
- 适用人群为AAST 1-2级、无其他重大损伤、无合并症及腹外手术的<16岁患儿;合并症、其他重大损伤或腹外手术者被排除,不适用该结论。
- 原文强调需前瞻性研究验证门诊管理安全性后方可改变常规收治策略,不能仅凭本回顾性数据直接让患儿离院。
指南或共识出处
- 原文未提及具体指南或共识名称;数据来源为美国外科医师学会创伤质量改进计划(TQIP)登记(2007-2017)。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Children with low-grade blunt solid organ injury (SOI) have historically been admitted to an inpatient setting for monitoring, but the evidence supporting the necessity of this practice is lacking. The purpose of this study was to quantify the frequency and timing of intervention for hemorrhage and to describe hospital-based resource utilization for low-grade SOI in the absence of other major injuries (OMIs).
METHODS: A cohort of children (aged <16 years) with blunt American Association for the Surgery of Trauma grade 1 or 2 SOI from the American College of Surgeons Trauma Quality Improvement Program registry (2007-2017) was analyzed. Children were excluded if they had confounding factors associated with intervention for hemorrhage (comorbidities, OMIs, or extra-abdominal surgical procedures). Outcomes included frequency and timing of intervention (laparotomy, angiography, or transfusion) for hemorrhage, as well as hospital-based resource utilization.
RESULTS: A total of 1,019 children were identified with low-grade blunt SOI and no OMIs. Nine hundred eighty-six (96.8%) of these children were admitted to an inpatient unit. Admitted children with low-grade SOI had a median length-of-stay of 2 days and a 23.9% intensive care unit admission rate. Only 1.7% (n = 17) of patients with low-grade SOI underwent an intervention, with the median time to intervention being the first hospital day. No child who underwent angiography was transfused or had an abnormal initial ED shock index.
CONCLUSION: Children with low-grade SOI are routinely admitted to the hospital and often to the intensive care unit but rarely undergo hospital-based intervention. The most common intervention was angiography, with questionable indications in this cohort. These data question the need for inpatient admission for low-grade SOI and suggest that discharge from the emergency room may be safe. Prospective investigation into granular risk factors to identify the rare patient needing hospital-based intervention is needed, as is validation of the safety of ambulatory management.
LEVEL OF EVIDENCE: Prognostic and epidemiological, level III.
参考来源
- Evans LL, Williams RF, Jin C, et al. Hospital-based intervention is rarely needed for children with low-grade blunt abdominal solid organ injury: An analysis of the Trauma Quality Improvement Program registry. J Trauma Acute Care Surg. 2021. PMID: 34559162. doi:10.1097/TA.0000000000003206
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。